Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors (Q39560418)

13 September 2017

title

Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors (English)

1 reference

13 September 2017

0 references

1 reference

1 reference

0 references

Xing-gang Mao

1

1 reference

13 September 2017

Ming Yan

2

1 reference

13 September 2017

Xiao-yan Xue

3

1 reference

13 September 2017

Xiang Zhang

4

1 reference

13 September 2017

Hong-gang Ren

5

1 reference

13 September 2017

Geng Guo

6

1 reference

13 September 2017

Peng Wang

7

1 reference

13 September 2017

Wei Zhang

8

1 reference

13 September 2017

Jun-li Huo

9

1 reference

13 September 2017

publication date

11 April 2011

1 reference

13 September 2017

published in

Laboratory Investigation

1 reference

13 September 2017

volume

91

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

1068-1078

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

21 January 2018

Brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Progress on potential strategies to target brain tumor stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

O2 regulates stem cells through Wnt/β-catenin signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Hypoxia-inducible factors, stem cells, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

The impact of O2 availability on human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Hypoxia signalling in cancer and approaches to enforce tumour regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Maintenance of critical properties of brain tumor stem-like cells after cryopreservation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Cancer stem cells: controversial or just misunderstood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response Machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

BMI1 sustains human glioblastoma multiforme stem cell renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Specific recognition of ZNF217 and other zinc finger proteins at a surface groove of C-terminal binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Regulation of LSD1 histone demethylase activity by its associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

Transcriptional regulation by C-terminal binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

The ZNF217 oncogene is a candidate organizer of repressive histone modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.56

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2011.56

1 reference

Dimensions Publication ID

13 September 2017

1025709572

0 references

Fatcat ID

release_dblgcr2bkvcbbnivcl77tk6d7q

0 references

1 reference